The TMPRSS6 gene helps control how much iron your body absorbs by keeping hepcidin, a hormone that limits iron uptake, in balance. If this gene does not work well, iron can stay too low, leading to iron deficiency anemia with tiredness, pale skin, and small red blood cells, often with little response to iron tablets. Understanding this gene can help make sense of ongoing iron deficiency that does not improve much with standard treatment. Pathogenic variants in the TMPRSS6 gene are a known cause of inherited iron-refractory iron deficiency anemia.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Others mainly help direct when certain processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can find more in the LearnHub.
Overview
TMPRSS6Gene function
What if the gene works
The TMPRSS6 gene helps control hepcidin, a hormone that limits how much iron your body absorbs. By lowering hepcidin when iron is needed, it supports healthy iron levels and red blood cell production.
Risk
What if the gene does not work
Variants in the TMPRSS6 gene can reduce the body's ability to handle iron, leading to iron deficiency anemia that often starts in childhood. Milder or more severe variants may affect when it appears and how marked the anemia becomes.
Treatment
What does that mean for your treatment
Pathogenic variants in the TMPRSS6 gene often mean standard oral iron works poorly, so treatment usually relies more on intravenous iron. Hemoglobin can improve, but the response is often partial and some people need repeated courses to maintain iron levels.
Conditions associated with TMPRSS6
Gene function
What if the gene works
Your liver uses the TMPRSS6 gene to fine tune iron balance from day to day. In everyday terms, this gene helps regulate iron levels in the body by adjusting a signal called hepcidin, which controls how much iron is absorbed from food and released into the blood.
In the liver, the TMPRSS6 gene helps set the level of hepcidin, a hormone that tells the body when to hold back iron. Its protein acts at the surface of liver cells to tone down signals that would otherwise push hepcidin higher.
When hepcidin stays in the right range, your gut can absorb iron from food more appropriately. This supports the steady iron supply your body needs to make hemoglobin, the part of red blood cells that carries oxygen.
The TMPRSS6 gene also supports the release of iron from body stores into the bloodstream when iron is needed. By guiding this day to day balance, it helps keep iron available for routine tasks across the body.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many TMPRSS6 gene variants make the protein shorter, unstable, or less active, so liver cells may keep hepcidin too high. This is how TMPRSS6 gene variants can reduce iron absorption and iron release into the blood. Milder variants may leave some protein activity, while more severe variants can remove most activity and are often linked to earlier or more persistent iron deficiency anemia.
How variants are linked to conditions
Pathogenic variants in the TMPRSS6 gene can cause iron-refractory iron deficiency anemia, an inherited condition marked by ongoing iron deficiency anemia and a poor response to oral iron. In population studies, some common TMPRSS6 gene variants are also linked to lower iron levels and a higher chance of iron deficiency anemia, but these risk associations do not confirm a diagnosis on their own.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a clear diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TMPRSS6-related iron deficiency, risk is mainly set by the gene change itself rather than lifestyle. Blood loss, low iron intake, pregnancy, and heavy menstrual periods can make low iron more noticeable or more severe, but there is not enough evidence to say lifestyle changes prevent the condition itself.
Inheritance of TMPRSS6 variants
TMPRSS6 gene variants linked to iron-refractory iron deficiency anemia are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the TMPRSS6 gene from each parent. Parents who each carry one variant are often unaffected themselves, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without the familial variants. Boys and girls are affected equally because the TMPRSS6 gene is on an autosome, not a sex chromosome.
What does my TMPRSS6 result mean for my family?
For families with a disease-causing TMPRSS6 result linked to iron-refractory iron deficiency anemia, brothers and sisters may also have the condition or be carriers, even if their symptoms differ. Parents are often healthy carriers. Children usually are not affected unless the other parent also carries a disease-causing TMPRSS6 change, but they may be carriers.
Genetic information
Genetic testing
How you find out about variants
TMPRSS6 genetic testing looks for changes in the TMPRSS6 gene using a blood sample or cheek swab. A lab reads the gene’s DNA code to see whether a variant is present, which can help confirm or clarify inherited iron-refractory iron deficiency anemia in the right clinical setting.
When should I consider getting a genetic test?
Consider TMPRSS6 testing if you or your child has ongoing iron deficiency anemia that does not improve as expected with iron pills, especially when it starts in childhood or runs in the family. A result can help confirm a rare inherited cause of low iron levels and explain why standard iron treatment may work poorly.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies based on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to a drug differently. These inherited differences are common and are one reason medication response is not the same for everyone. In some cases, genetics helps explain why someone is more sensitive to a medicine or why a standard treatment has a weaker effect.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently from one person to another. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the TMPRSS6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so general questions about side effects, new symptoms, or treatment changes are best discussed with your doctor. Research on the TMPRSS6 gene has mainly focused on iron balance and how rare inherited changes may affect response to iron treatment, but this is not part of routine medication guidance.
History
In the early 2000s, researchers identified the TMPRSS6 gene while mapping a group of related human protease genes, a step that opened a new chapter in iron biology. Soon after, rare inherited changes in this gene were linked to iron-refractory iron deficiency anemia, a form of anemia that does not improve as expected with standard iron treatment. From these first observations, research expanded steadily. Studies in families and animal models helped confirm that TMPRSS6 was central to this unusual pattern of low iron and helped explain why some people remained anemic despite supplementation. Over time, this work reshaped how clinicians understood certain inherited iron problems and led to more precise genetic diagnosis in affected families.